Riordan NH, Hincapié ML, Morales I, Fernández G, Allen N, Leu C, Madrigal M, Paz Rodríguez J, Novarro N.
Stem Cells Transl Med. 2019 Oct;8(10):1008-1016
Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
Riordan, NH; Morales, I; Fernández, G; Allen, N; Fearnot, NE; Leckrone, ME; Markovich, DJ; Mansfield, D; Avila, D; Patel, AN; Kesari, S; Paz Rodriguez, J.
J Transl Med. 2018 Mar 9; 16:57
Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood.
Mikirova NA, Kesari S, Ichim TE, Riordan NH.
J Transl Med. 2017 Oct 20;15(1):213.
High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report.
Mikirova N, Hunnunghake R, Scimeca RC, Chinshaw C, Ali F, Brannon
C, Riordan N.
Am J Case Rep. 2016 Oct 24;17:774-781.
Safety of targeting tumor endothelial cell antigens.
Wagner SC, Riordan NH, Ichim TE, Szymanski J, Ma H, Perez JA, Lopez J, Plata-Munoz JJ, Silva F, Patel AN, Kesari S
J Transl Med. 2016 Apr 12;14:90.
Case report of non-healing surgical wound treated with dehydrated human amniotic membrane.
Riordan NH, George BA, Chandler TB, McKenna RW
J Transl Med. 2015 Jul 24;13:242.
Minimally Invasive Autologous Bone Marrow Concentrate Stem Cells in the Treatment of the Chronically Injured Achilles Tendon: A Case Report
McKenna R. W., Riordan N. H.
CellR4 2014; 2 (4): e1100
Update on: Minimally Invasive Autologous Bone Marrow Concentrate Stem Cells in the Treatment of the Chronically Injured Achilles Tendon: a Case Report
Riordan N H, McKenna R W
CellR4 2015; 3 (1): e1366
Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagents.
Riordan NH, Madrigal M, Reneau J, de Cupeiro K, Jiménez N, Ruiz S, Sanchez N, Ichim TE, Silva F, Patel AN.
J Transl Med. 2015 Jul 17;13:232.
A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods.
Madrigal M, Rao KS, Riordan NH.
J Transl Med. 2014 Oct 11;12:260.
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
Wagner SC, Markosian B, Ajili N, Dolan BR, Kim AJ, Alexandrescu DT, Dasanu CA, Minev B, Koropatnick J, Marincola FM, Riordan NH.
J Transl Med. 2014 May 13;12:127. doi: 10.1186/1479-5876-12-127.
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
Mikirova N, Casciari J, Riordan N, Hunninghake R.
J Transl Med. 2013 Aug 15;11(1):191.
Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis.
Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T.
J Orthomol Med. 2012 Jan 1; 27(1): 9–12.
The bio-energetic theory of carcinogenesis.
Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N.
Med Hypotheses. 2012 Oct;79(4):433-9. doi: 10.1016/j.mehy.2012.06.015.
Rodriguez JP, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH.
Int Arch Med. 2012 Feb 8;5:5. doi: 10.1186/1755-7682-5-5.
The king is dead, long live the king: entering a new era of stem cell research and clinical development.
Ichim T, Riordan NH, Stroncek DF.
J Transl Med. 2011 Dec 20;9:218. doi: 10.1186/1479-5876-9-218.
IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?
Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Dasanu CA.
J Immunother. 2011 Oct;34(8):607-609.
Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury.
Jiang N, Zhang X, Zheng X, Chen D, Zhang Y, Siu LK, Xin HB, Li R, Zhao H, Riordan N, Ichim TE, Quan D, Jevnikar AM, Chen G, Min W.
Am J Transplant. 2011 Sep;11(9):1835-44. doi: 10.1111/j.1600-6143.2011.03660.x. Epub 2011 Jul 27.
Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
Mansilla E, Díaz Aquino V, Zambón D, Marin GH, Mártire K, Roque G, Ichim T, Riordan NH, Patel A, Sturla F, Larsen G, Spretz R, Núñez L, Soratti C, Ibar R, van Leeuwen M, Tau JM, Drago H, Maceira A.
Stem Cells Int. 2011;2011:943216. doi: 10.4061/2011/943216. Epub 2011 Jun 13.
Increased Level of Circulating Endothelial Microparticles and Cardiovascular Risk Factors.
Mirikova N, Casciari J, Hunninghake R, Riordan N.
J Clinic Experiment Cardiol. 2011 April 5;2:131.
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda Massari JR, Alexandrescu DT, Dasanu C, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH.
J Transl Med. 2011 Mar 4;9(1):25.
On the missing link between inflammation and cancer.
Alexandrescu DT, Riordan NH, Ichim TE, Kauffman CL, Kabigting F, Dutton CT, Dasanu CA.
Dermatol Online J. 2011 Jan 15;17(1):10.
Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.
Alexandrescu DT, Kauffman CL, Ichim TE, Riordan NH, Kabigting F, Dasanu CA.
Dermatol Online J. 2011 Jan 15;17(1):2.
Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model.
Mansilla E, Spretz R, Larsen G, Nuñez L, Drago H, Sturla F, Marin GH, Roque G, Martire K, Díaz Aquino V, Bossi S, Gardiner C, Lamonega R, Lauzada N, Cordone J, Raimondi JC, Tau JM, Biasi NR, Marini JE, Patel AN, Ichim TE, Riordan N, Maceira A.
Transplant Proc. 2010 Dec;42(10):4275-8.
Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4.
Zhang Y, Peng T, Zhu H, Zheng X, Zhang X, Jiang N, Cheng X, Lai X, Shunnar A, Singh M, Riordan N, Bogin V, Tong N, Min WP.
J Transl Med. 2010 Dec 15;8:133.
Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.
Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH.
Int Arch Med. 2010 Nov 11;3:30.
Vitamin D concentrations, endothelial progenitor cells, and cardiovascular risk factors.
Mikirova NA, Belcaro G, Jackson JA, Riordan NH.
Panminerva Med. 2010 Jun;52(2 Suppl 1):81-7.
Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?
Ichim TE, Zhong Z, Mikirova NA, Jackson JA, Hunninghake R, Mansilla E, Marín G, Núñez L, Patel AN, Angle N, Murphy MP, Dasanu CA, Alexandrescu DT, Bogin V, Riordan NH.
Panminerva Med. 2010 Jun;52(2 Suppl 1):75-80.
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.
Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X.
J Transl Med. 2010 Aug 3;8:75.
Immunotherapy for melanoma: current status and perspectives.
Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Di Nardo A, Kabigting FD, Dasanu CA.
J Immunother. 2010 Jul-Aug;33(6):570-90.
Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease.
Ichim TE, Harman RJ, Min WP, Minev B, Solano F, Rodriguez JP, Alexandrescu DT, DeNecochea-Campion R, Hu X, Marleau AM, Riordan NH.
Cell Immunol. 2010;264(1):7-17. Epub 2010 Apr 8.
Tumor vaccines in 2010: need for integration.
Koos D, Josephs SF, Alexandrescu DT, Chan RC, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Riordan NH, Carrier E.
Cell Immunol. 2010;263(2):138-47. Epub 2010 Apr 3.
Combination stem cell therapy for heart failure.
Ichim TE, Solano F, Lara F, Rodriguez JP, Cristea O, Minev B, Ramos F, Woods EJ, Murphy MP, Alexandrescu DT, Patel AN, Riordan NH.
Int Arch Med. 2010 Apr 14;3(1):5.
Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.
Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Ramos F, Ichim TE, Riordan NH.
J Transl Med. 2010 Apr 8;8:34.
The lysosomotropic agent, hydroxychloroquine, delivered in a biodegradable nanoparticle system, overcomes drug resistance of B-chronic lymphocytic leukemia cells in vitro.
Mansilla E, Marin GH, Nuñez L, Drago H, Sturla F, Mertz C, Rivera L, Ichim T, Riordan N, Raimondi C.
Cancer Biother Radiopharm. 2010 Feb;25(1):97-103.
The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells.
Drago H, Marín GH, Sturla F, Roque G, Mártire K, Díaz Aquino V, Lamonega R, Gardiner C, Ichim T, Riordan N, Raimondi JC, Bossi S, Samadikuchaksaraei A, van Leeuwen M, Tau JM, Núñez L, Larsen G, Spretz R, Mansilla E.
Transplant Proc. 2010 Jan-Feb;42(1):345-9.
Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo.
Mikirova NA, Casciari JJ, Riordan NH.
J Angiogenes Res. 2010 Jan 18;2:2.
Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, Minev B, Patel AN, Murphy MP, Smith L, Alexandrescu DT, Ichim TE, Riordan NH.
J Transl Med. 2009 Dec 15;7:106.
Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.
Ichim TE, Alexandrescu DT, Solano F, Lara F, Campion Rde N, Paris E, Woods EJ, Murphy MP, Dasanu CA, Patel AN, Marleau AM, Leal A, Riordan NH.
Cell Immunol. 2010;260(2):75-82.
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.
Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B.
J Transl Med. 2009 Apr 24;7:29.
Feasibility investigation of allogeneic endometrial regenerative cells.
Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, Woods EJ, Reid M, Mansilla E, Marin GH, Drago H, Murphy MP, Minev B.
J Transl Med. 2009 Feb 20;7:15.
Inhibition of intracranial glioma growth by endometrial regenerative cells.
Han X, Meng X, Yin Z, Rogers A, Zhong J, Rillema P, Jackson JA, Ichim TE, Minev B, Carrier E, Patel AN, Murphy MP, Min WP, Riordan NH.
Cell Cycle. 2009 Feb 15;8(4):606-10. Epub 2009 Mar 2.
Anti-angiogenic effect of high doses of ascorbic acid.
Mikirova NA, Ichim TE, Riordan NH.
J Transl Med. 2008 Sep 12;6:50.
Allogeneic endometrial regenerative cells: an “Off the shelf solution” for critical limb ischemia?
Murphy MP, Wang H, Patel AN, Kambhampati S, Angle N, Chan K, Marleau AM, Pyszniak A, Carrier E, Ichim TE, Riordan NH.
J Transl Med. 2008 Aug 19;6:45.
Granulocyte activity in patients with cancer and healthy subjects.
Mikirova NA, Klykov AA, Jackson JA, Riordan NH.
Cancer Biol Ther. 2008 Sep;7(9):1362-7. Epub 2008 Sep 2.
Exosomes as a tumor immune escape mechanism: possible therapeutic implications.
Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH.
J Transl Med. 2008 Jul 22;6:37.
Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
Leal A, Ichim TE, Marleau AM, Lara F, Kaushal S, Riordan NH.
Cell Immunol. 2008 May-Jun;253(1-2):11-5. Epub 2008 Jul 15.
Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy.
Ichim TE, Solano F, Brenes R, Glenn E, Chang J, Chan K, Riordan NH.
Reprod Biomed Online. 2008 Jun;16(6):898-905.
Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH.
P R Health Sci J. 2008 Mar;27(1):7-19.
Antigen-specific therapy of rheumatoid arthritis.
Ichim TE, Zheng X, Suzuki M, Kubo N, Zhang X, Min LR, Beduhn ME, Riordan NH, Inman RD, Min WP.
Expert Opin Biol Ther. 2008 Feb;8(2):191-9.
Endometrial regenerative cells: a novel stem cell population.
Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, Wang H, Ge W, Bogin V, Chan KW, Thébaud B, Riordan NH.
J Transl Med. 2007 Nov 15;5:57.
Stem cell therapy for autism.
Ichim TE, Solano F, Glenn E, Morales F, Smith L, Zabrecky G, Riordan NH.
J Transl Med. 2007 Jun 27;5:30.
Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer.
Duconge J, Miranda-Massari JR, González MJ, Taylor PR, Riordan HD, Riordan NH, Casciari JJ, Alliston K.
Ann Pharmacother. 2007 Jun;41(6):1082-3. Epub 2007 May 22.
Cord blood in regenerative medicine: do we need immune suppression?
Riordan NH, Chan K, Marleau AM, Ichim TE.
J Transl Med. 2007 Jan 30;5:8.
Therapeutic use of Aldara in chronic myeloid leukemia.
Marleau AM, Lipton JH, Riordan NH, Ichim TE.
J Transl Med. 2007 Jan 25;5:4.
Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics.
González MJ, Herrera FL, Miranda-Massari JM, Guzmán AM, Riordan NH, Ricart CM.
P R Health Sci J. 2006 Mar;25(1):71-3.
Induction of antitumor immunity through xenoplacental immunization.
Zhong Z, Kusznieruk KP, Popov IA, Riordan NH, Izadi H, Yijian L, Sher S, Szczurko OM, Agadjanyan MG, Tullis RH, Harandi A, Reznik BN, Mamikonyan GV, Ichim TE.
J Transl Med. 2006 May 25;4:22.
A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.
Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.
P R Health Sci J. 2005 Dec;24(4):269-76.
A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures.
Ichim TE, Popov IA, Riordan NH, Izadi H, Zhong Z, Yijian L, Sher S, Oleinik EK.
J Transl Med. 2006 Jan 3;4:2.
Cancer is a functional repair tissue.
Meng X, Riordan NH.
Med Hypotheses. 2006;66(3):486-90. Epub 2005 Nov 15.
Orthomolecular oncology review: ascorbic acid and cancer 25 years later.
González MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A.
Integr Cancer Ther. 2005 Mar;4(1):32-44.
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.
P R Health Sci J. 2004 Jun;23(2):115-8.
Cell membrane fatty acid composition differs between normal and malignant cell lines.
Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, González MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W.
P R Health Sci J. 2004 Jun;23(2):103-6.
L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.
Han SS, Kim K, Hahm ER, Lee SJ, Surh YJ, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang JH, Yoon SS, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee JH, Park S.
J Cell Biochem. 2004 Oct 1;93(2):257-70.
Intravenous ascorbic acid: protocol for its application and use.
Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, González MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A.
P R Health Sci J. 2003 Sep;22(3):287-90.
Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLITE-FLITE randomized, controlled trial.
Cesarone MR, Belcaro G, Nicolaides AN, Ricci A, Geroulakos G, Ippolito E, Brandolini R, Vinciguerra G, Dugall M, Griffin M, Ruffini I, Acerbi G, Corsi M, Riordan NH, Stuard S, Bavera P, Di Renzo A, Kenyon J, Errichi BM.
Angiology. 2003 Sep-Oct;54(5):531-9.
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.
Meng XL, Riordan NH, Casciari JJ, Zhu Y, Zhong J, González MJ, Miranda-Massari JR, Riordan HD.
P R Health Sci J. 2002 Dec;21(4):323-8.
Orthomolecular oncology: a mechanistic view of intravenous ascorbate’s chemotherapeutic activity.
González MJ, Miranda-Massari JR, Mora EM, Jiménez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH, Rodríguez M, Guzmán A.
P R Health Sci J. 2002 Mar;21(1):39-41.
Inhibition of human breast carcinoma cell proliferation by ascorbate and copper.
González MJ, Mora EM, Miranda-Massari JR, Matta J, Riordan HD, Riordan NH.
P R Health Sci J. 2002 Mar;21(1):21-3.
Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.
Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD.
Br J Cancer. 2001 Jun 1;84(11):1544-50.
Integrative medicine: a paradigm shift in medical education and practice.
González MJ, Miranda-Massari JR, Mora EM, Cruzado NA, Jiménez I, Rosa M, Matos Vera MI, Santiago C, Román-Eyxarch MI, Rodríguez JR, Pérez Cortés C, Riordan NH, Riordan HD, Ricart CM.
P R Health Sci J. 2000 Dec;19(4):389-92.
The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary.
González MJ, Riordan NH.
Med Hypotheses. 1996 Jun;46(6):503-4.
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.
Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA.
Med Hypotheses. 1995 Mar;44(3):207-13.
Improved microplate fluorometer counting of viable tumor and normal cells.
Riordan HD, Riordan NH, Meng X, Zhong J, Jackson JA.
Anticancer Res. 1994 May-Jun;14(3A):927-31.
Neil Riordan 9-29-2011
www.neilriordan.net